Novo Nordisk A/S ADR (NY: NVO )

105.06 +2.43 (+2.37%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form SC 13G/A
Source: SEC/Edgar
February 12, 2014
Form SC 13G/A
Source: SEC/Edgar
February 12, 2014
Form 6-K
Source: SEC/Edgar
February 10, 2014
Form 6-K
Source: SEC/Edgar
February 09, 2014
Form 6-K
Source: SEC/Edgar
February 04, 2014
Form 20-F
Source: SEC/Edgar
February 04, 2014
Form IRANNOTICE
Source: SEC/Edgar
February 04, 2014
Form 6-K
Source: SEC/Edgar
February 03, 2014
Form 6-K
Source: SEC/Edgar
January 29, 2014
Form 6-K
Source: SEC/Edgar
January 28, 2014
Form 6-K
Source: SEC/Edgar
January 20, 2014
Form 6-K
Source: SEC/Edgar
January 13, 2014
Form 6-K
Source: SEC/Edgar
January 01, 2014
Form 6-K
Source: SEC/Edgar
December 30, 2013
Form 6-K
Source: SEC/Edgar
December 29, 2013
Form 6-K
Source: SEC/Edgar
December 29, 2013
Form 6-K
Source: SEC/Edgar
December 16, 2013
Form 6-K
Source: SEC/Edgar
December 09, 2013
Form F-6EF
Source: SEC/Edgar
December 09, 2013
Form 6-K
Source: SEC/Edgar
December 08, 2013
Form 6-K
Source: SEC/Edgar
December 02, 2013
Form 6-K
Source: SEC/Edgar
December 01, 2013
Form 6-K
Source: SEC/Edgar
November 24, 2013
Form 6-K
Source: SEC/Edgar
November 19, 2013
Form 6-K
Source: SEC/Edgar
November 11, 2013
Form 6-K
Source: SEC/Edgar
October 31, 2013
Form 6-K
Source: SEC/Edgar
October 30, 2013
Form 6-K
Source: SEC/Edgar
October 29, 2013
Form 6-K
Source: SEC/Edgar
October 21, 2013
Form 6-K
Source: SEC/Edgar
October 06, 2013
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.